Quandify develops an intelligent water meter system for residential property owners that enables sub-metering cost-efficiently. The company’s platform uses machine learning to break down water usage data into outlets and diagnoses an entire homes water and hot water energy usage from a single, patented, non-invasive sensor. In our smartphone app, tenants then receive individually tailored nudges on how to efficiently lower usage, without sacrificing comfortability. The result is an up to 40 % decrease in water usage on average, and as a result, an energy usage reduction of 8 - 16 %, paving the way for a more sustainable and aware public and private residential real estate industry. Watch our video presentation below: https://quandify.com/about/

Turbulent Flux develops a new flow simulator technology with innovative choices to support Oil&Gas field personnel in their daily asset operations. We have since our start-up in 2016 been joined by others with key experience and networks in flow simulator development, petroleum engineering, asset management, cloud computing, data analysis, machine learning, and venture development. The ongoing digitalization in the Oil & Gas industry is accompanied with a smaller workforce that take on larger workloads. New demand is set to expert systems that support field personnel in their daily production decisions. The fluid flow in wells and pipelines is key information for any producing asset. The fluid flow can be modelled and key data can be immediately transmitted to the user with physical based simulator solutions that use real time data from sensors and equipment. Today, these simulator solutions are of limited use by the industry as the technology has performance issues in real time environment and is expensive to install and maintain. Users are looking for a new innovative solution that can support their increased daily workload and be easily maintained by themselves.

iNANOD AS is a nanotechnology based anticancer drug developing company operating from Oslo Cancer Cluster Incubator established in 2016.  The objective is to increase efficacy of cancer drugs and to reduce unintended side-effects for cancer patients and maximize their longevity. We have a strong group of people to deliver on the promise which comprises of our collaborators, scientific advisors and business advisors.   Our aim is to become a pharmaceutical company for anti cancer nanomedicines.  We will take a comprehensive approach, using collaborative research from many small projects and existing literature and infrastructure. Our team consisting of experts within nanotechnology, biology, chemistry, pharmacy and medicine. Our partnerships with research institutions, makes us well suited for developing and commercialising this technology. As the focus is on improved delivery, the technology can greatly improve safety and efficacy of existing cancer drugs. Moreover, the costly development of new drugs will not be necessary. Monetisation and exit will therefore be available in an earlier phase than normal within pharmaceutical development, through selling IPR to established pharmaceutical companies after clinical phase IIa. The Norwegian Research Council has granted our pre-project application in NANO 2021 call and research has started in August 2017. Innovasjon Norge has also supported us with mentoring hours. We are a member of Oslo Cancer Cluster now.

Atelier is a digital platform that lets you discover and buy art directly from professional and emerging artists. Our goal is to make art more accessible and contribute to a richer art market and better economic conditions for the artists.Since launch in April 2018 nearly 300 of the most exciting and promising artists from Oslo and Bergen have created profiles and uploaded over 1000 artworks.View their art by downloading the iOS app:appsto.re/no/vuVTib or visit atelier.as

Areo gives facility managers and buildings owners new ways to get their work done. Building data and history are tracked and made accessible in a shared online repository. The system supports open standards in the building and IT industries. The system connects building information models, documents, processes and collaborative content.

Byrd is a platform for verified user-generated content. In other words, we’re making a web- and smartphone app where private people can sell their photos and videos to news organizations. Our users can respond to assignments from media or upload content they consider newsworthy. Our vision is to innovate and empower storytelling by providing photographers and media outlets with powerful tools in order to get the best truthful news coverage possible.

We are an elite unit of consultants from across the Nordics who believe we can create a better consulting experience for our customers. We are who you engage when you want to take commercial and digital execution to the next level. We move mast, with specialised resources and technology. Our customers are both corporates and startups with the highest ambition in their respective industries.

Only 7.9% of new medicin is approved for phase 1 clinical programs - life saving cures are being scrapped because of poor reproducibility. Today, researchers designing complex in vitro and in vivo experiments jump between many tools that do not talk to each other. Protocols are written in free text, naming is inconsistent, raw data is scattered across drives, and inventory and cell banks are tracked separately. This makes it hard to reproduce experiments, compare results across projects, trace which cell material went into which batch, and satisfy regulatory expectations. Small and mid-sized labs often cannot afford enterprise platforms like Benchling or Dotmatics, so they manually glue everything together and rarely get to use advanced analytics or AI. BioPilot solves this by standardising the full early-to-in-vivo CTR pipeline in one product. Users can register and template in vitro experiments (differentiation, expansion, cryopreservation, device testing, etc.) and in vivo studies (animals, groups, dosing, housing, ethics documents) using fixed ontologies. This gives every experiment a structured schema and a precise schedule of readouts, barcodes and data types to collect. Raw data (FACS, scRNA-seq, imaging, counters, bioreactor logs, etc.) is then automatically linked back to the right experiment, condition and sample. On top of this, BioPilot offers: • Inventory and cell bank tracking that makes it trivial to trace which vial, edit or expansion batch was used where. • Live bioreactor monitoring with alarms (email / phone) to prevent losing expensive batches. • A growing library of free analytical tools, including automated FACS gating, scRNA-seq pipelines and image analysis that can feed results straight back into the experiment records. • A global ontology service for vendors, instruments, cell lines, species and process terms, with a roadmap for a public API. Because everything is structured and queryable, BioPilot makes it much easier to compare experiments, run Bayesian optimisation on process parameters, and let AI suggest next-step experiments. The pricing is kept aggressively low (free tier plus a simple paid tier based on storage), so smaller biotech and academic groups can access capabilities that are normally reserved for organisations with large software budgets. In short, BioPilot aims to become the operating system for cell therapy R&D: a single, affordable platform where experiments are planned, executed, monitored and analysed in a way that is standardised enough for automation and flexible enough for real-world biology.

DFRNT provides the world’s most reliable business information exchange through the platform for justified trust; including model-based business reporting infrastructure with the Twinfox product; and semantic data hub solutions through the DFRNT Studio product. The Twinfox and DFRNT Studio product suites enables business professionals to replace current manual error-prone information processing with spreadsheet software for financial planning and analysis, with effective and efficient processes where quality control is built into the information toolchain, enabling business professionals to achieve high quality results significantly faster, better and cheaper than today.

Safety meets simplicity. Heyon is a Swedish security startup offering a completely reimagined home alarm service. Our connected solution combines smart technology, professional monitoring, and on-site response. All at a uniquely low monthly cost. Simple, accessible, and built for the modern consumer.

Lyfta is the fastest-growing strength-training platform in the world, created to turn everyday training into lasting results. We’re solving fitness’s biggest problem: building the consistency and structure people need to keep getting stronger week after week. While others chase engagement, Lyfta builds consistency. With millions already training through our platform, we’re creating the world’s most powerful strength ecosystem.

We’re a community organisation aiming to build a world-class startup ecosystem in Aarhus backed by amazing stakeholders such as Aarhus University, Business Academy Aarhus, VIA University, The City Council of Aarhus, and Region Midtjylland. At Startup Aarhus we initiate programs and activities, that help solve our founder’s biggest challenges. Whether it’s securing funding, building networks, or gaining insights, we’re here to help you move forward, and make it easier for startups to change the world.

VentriJect is developing the groundbreaking Seismofit® System, a health solution that uses advanced seismocardiography and an AI algorithm to help healthcare and wellness providers assess cardiorespiratory fitness (CRF) accurately and efficiently, without physical exercise. Cardiorespiratory fitness (CRF), often measured by VO₂max, is a powerful predictor of long-term health and a key indicator of a person's risk for chronic diseases. Unfortunately, current methods for measuring VO₂max are often complex, time-consuming, and require a high-intensity physical effort (e.g., on a treadmill), which makes them inaccessible to many, especially the elderly, those with mobility issues, or patients recovering from illness. This widespread problem affects millions of people globally who could benefit from a simple, accurate, and non-invasive way to assess their fitness levels. We have developed the Seismofit® System, an award-winning medical device that revolutionizes CRF measurement. Our solution uses advanced seismocardiography—a technology that records the micro-vibrations of the chest caused by heartbeats—in combination with a sophisticated AI algorithm. In under three minutes, our system provides a highly accurate estimate of VO₂max without the need for any physical exercise. This fast, simple, and non-invasive process makes it possible for healthcare and wellness providers to easily integrate CRF assessments into routine check-ups, helping them provide more personalized care and better disease prevention strategies. The spark for VentriJect was ignited by a clear unmet need in the healthcare industry. We recognized that while VO₂max is a vital health metric, its assesment was limited to specialized settings due to the demanding nature of existing tests. This created a barrier to widespread adoption, preventing countless individuals from understanding and improving their cardiorespiratory health. Our team was motivated to bridge this gap by creating a technology that could democratize access to this critical health data. By making CRF assessments simple and accessible, we are not just building a product; we are empowering healthcare providers and patients to take a proactive approach to health, with the ultimate goal of improving quality of life for millions.

1990 Studio makes mobile software for startups that take craft seriously. Copenhagen-based, current team of six. AI engineers, iOS and full-stack developers, designers. We work with North American clients building at the intersection of mobile and AI. Projects from concept to launch, or refinement work on products that need a layer of intention. We believe software should look and feel better than it does. The best digital products blend into daily life because someone made a hundred small decisions correctly. Design and development from the same brain. Competent execution meeting taste you can't shortcut through tutorials. We're building toward creative autonomy, not scale. Looking for iOS developers. Build something great with us.

🌍 About Xbrandify Xbrandify is an AI-powered, white-label experiential travel platform that helps brands turn their audiences into communities—and their marketing into revenue. We empower lifestyle, sports, and media brands to launch their own travel platforms where they can offer everything from curated local activities to full-scale adventures—without needing to build any tech or operations themselves. 🚨 The Problem We're Solving In a world of banner blindness, short attention spans, and rising ad costs, traditional marketing is losing its impact. At the same time, experiential marketing—creating memorable, real-world brand moments—is outperforming static campaigns. But most brands lack the tools or infrastructure to deliver meaningful experiences at scale. Travel is one of the most powerful experiential touchpoints in the world—but it’s underused and difficult to execute. ✅ Our Solution Xbrandify turns travel into a scalable experiential marketing engine. We provide: - A white-label travel platform for brands to launch their own booking site - A library of curated experiential travel products (local and global) - A system to engage communities and drive conversions, loyalty, and content - An AI-driven backend (AgentOS) to automate customer journeys and support Result: Brands grow community, loyalty, and revenue—all through branded experiences that inspire action. 💡 Why It Matters - Consumers are demanding experiences over ads, and community over clicks - Brands are sitting on untapped audiences with massive travel potential - New tools in AI and fintech now make this model scalable and profitable - We're giving brands a new kind of growth engine—experiential, emotional, and revenue-generating. Instead of spending on ads, brands use travel to engage their audience, create loyalty, and generate profit. Powered by automation and embedded fintech, we make it scalable.